コージンバイオ株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | Takato Nakamura | 2,209,500 | 43.20% | ¥2.7B | ¥22.1M |
| 2 | TAKAコーポレーション株式会社
Asset-management company of Takato Nakamura |
416,500 | 8.20% | ¥503M | ¥4.2M |
| 3 | GOLDMAN SACHS INTERNATIONAL | 389,478 | 7.60% | ¥471M | ¥3.9M |
| 4 | オリエンタル酵母工業株式会社 | 270,000 | 5.30% | ¥326M | ¥2.7M |
| 5 | BNY GCM CLIENT ACCOUNT JPRD AC ISG | 228,452 | 4.50% | ¥276M | ¥2.3M |
| 6 | 富士フイルム和光純薬株式会社 | 140,000 | 2.70% | ¥169M | ¥1.4M |
| 7 | コージンバイオ従業員持株会 | 118,579 | 2.30% | ¥143M | ¥1.2M |
| 8 | コスモ・バイオ株式会社 | 100,000 | 2.00% | ¥121M | ¥1.0M |
| 9 | 渡辺 恒美 | 78,900 | 1.50% | ¥95.3M | ¥789,000 |
| 10 | 家田化学薬品株式会社 | 72,000 | 1.40% | ¥87.0M | ¥720,000 |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Takato Nakamura | President & Representative Director | 2,626,000 | ¥3.2B | — |
| 中村 雄一 | Senior Managing Director | 53,000 | ¥64.0M | — |
| 對比地 久義 | Director | 23,070 | ¥27.9M | — |
| 原 稔 | Director | 10,000 | ¥12.1M | — |
| 山本 龍太朗 | Director | — | — | — |
| 山野 智也子 | Director | 200 | ¥241,619 | — |
| 森兼 康博 | Full-time Audit & Supervisory Board Member | 3,000 | ¥3.6M | — |
| 廣澤 一弘 | Audit & Supervisory Board Member | 3,000 | ¥3.6M | — |
| 梅津 英明 | Audit & Supervisory Board Member | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | ¥1,208 | ¥49.11 | 24.6x | ¥10.0 | 5,111,600 |
| FY ending Mar 2025 | ¥1,749 | ¥157.57 | 11.1x | ¥24.0 | 5,111,600 |
| FY ending Mar 2024 | ¥1,749 | ¥92.43 | — | ¥14.0 | 4,165,000 |